These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31313464)

  • 21. Wait-list mortality of young patients with Biliary atresia: Competing risk analysis of a eurotransplant registry-based cohort.
    van der Doef HPJ; van Rheenen PF; van Rosmalen M; Rogiers X; Verkade HJ;
    Liver Transpl; 2018 Jun; 24(6):810-819. PubMed ID: 29377411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.
    Kim WR; Mannalithara A; Heimbach JK; Kamath PS; Asrani SK; Biggins SW; Wood NL; Gentry SE; Kwong AJ
    Gastroenterology; 2021 Dec; 161(6):1887-1895.e4. PubMed ID: 34481845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
    Somsouk M; Kornfield R; Vittinghoff E; Inadomi JM; Biggins SW
    Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of the Pediatric End-Stage Liver Disease (PELD) growth failure thresholds on mortality among pediatric liver transplant candidates.
    Swenson SM; Roberts JP; Rhee S; Perito ER
    Am J Transplant; 2019 Dec; 19(12):3308-3318. PubMed ID: 31370108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex Disparity in Liver Transplant and Access to Living Donation.
    Karnam RS; Chen S; Xu W; Chen C; Elangainesan P; Ghanekar A; McGilvray I; Reichman T; Sayed B; Selzner M; Sapisochin G; Galvin Z; Hirschfield G; Asrani SK; Selzner N; Cattral M; Lilly L; Bhat M
    JAMA Surg; 2021 Nov; 156(11):1010-1017. PubMed ID: 34406347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinician assessments of health status predict mortality in patients with end-stage liver disease awaiting liver transplantation.
    Lai JC; Covinsky KE; Hayssen H; Lizaola B; Dodge JL; Roberts JP; Terrault NA; Feng S
    Liver Int; 2015 Sep; 35(9):2167-73. PubMed ID: 25644788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
    Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N
    Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients.
    Barshes NR; Lee TC; Udell IW; O'mahoney CA; Karpen SJ; Carter BA; Goss JA
    Liver Transpl; 2006 Mar; 12(3):475-80. PubMed ID: 16498644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Higher Mortality in registrants with sudden model for end-stage liver disease increase: Disadvantaged by the current allocation policy.
    Massie AB; Luo X; Alejo JL; Poon AK; Cameron AM; Segev DL
    Liver Transpl; 2015 May; 21(5):683-9. PubMed ID: 25762287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system.
    Genda T; Ichida T; Sakisaka S; Sata M; Tanaka E; Inui A; Egawa H; Umeshita K; Furukawa H; Kawasaki S; Inomata Y
    J Gastroenterol; 2014 Feb; 49(2):324-31. PubMed ID: 23478939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal Function Parameters and Serum Sodium Enhance Prediction of Wait-List Outcomes in Pediatric Liver Transplantation.
    Thalji L; Thalji NM; Heimbach JK; Ibrahim SH; Kamath PS; Hanson A; Schulte PJ; Haile DT; Kor DJ
    Hepatology; 2021 Mar; 73(3):1117-1131. PubMed ID: 32485002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting Outcomes on the Liver Transplant Waiting List in the United States: Accounting for Large Regional Variation in Organ Availability and Priority Allocation Points.
    Hart A; Schladt DP; Zeglin J; Pyke J; Kim WR; Lake JR; Roberts JP; Hirose R; Mulligan DC; Kasiske BL; Snyder JJ; Israni AK
    Transplantation; 2016 Oct; 100(10):2153-9. PubMed ID: 27490411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Re-weighting the model for end-stage liver disease score components.
    Sharma P; Schaubel DE; Sima CS; Merion RM; Lok AS
    Gastroenterology; 2008 Nov; 135(5):1575-81. PubMed ID: 18835388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver transplantation for hepatocellular carcinoma: the MELD impact.
    Sharma P; Balan V; Hernandez JL; Harper AM; Edwards EB; Rodriguez-Luna H; Byrne T; Vargas HE; Mulligan D; Rakela J; Wiesner RH
    Liver Transpl; 2004 Jan; 10(1):36-41. PubMed ID: 14755775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of ABO-incompatible listing on wait-list outcomes among infants listed for heart transplantation in the United States: a propensity analysis.
    Almond CS; Gauvreau K; Thiagarajan RR; Piercey GE; Blume ED; Smoot LB; Fynn-Thompson F; Singh TP
    Circulation; 2010 May; 121(17):1926-33. PubMed ID: 20404257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disparities in liver transplantation before and after introduction of the MELD score.
    Moylan CA; Brady CW; Johnson JL; Smith AD; Tuttle-Newhall JE; Muir AJ
    JAMA; 2008 Nov; 300(20):2371-8. PubMed ID: 19033587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An examination of liver offers to candidates on the liver transplant wait-list.
    Lai JC; Feng S; Roberts JP
    Gastroenterology; 2012 Nov; 143(5):1261-1265. PubMed ID: 22841780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tailoring allocation policies and improving access to paediatric liver transplantation over a 16-year period.
    Spada M; Angelico R; Trapani S; Masiero L; Puoti F; Colledan M; Cintorino D; Romagnoli R; Cillo U; Cardillo M;
    J Hepatol; 2024 Mar; 80(3):505-514. PubMed ID: 38122833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of MELD 30-allocation policy on liver transplant outcomes in Italy.
    Ravaioli M; Lai Q; Sessa M; Ghinolfi D; Fallani G; Patrono D; Di Sandro S; Avolio A; Odaldi F; Bronzoni J; Tandoi F; De Carlis R; Pascale MM; Mennini G; Germinario G; Rossi M; Agnes S; De Carlis L; Cescon M; Romagnoli R; De Simone P
    J Hepatol; 2022 Mar; 76(3):619-627. PubMed ID: 34774638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.